Yamaguchi syndrome: a rare type of hypertrophic cardiomyopathy
Authors:
Open Access
- 9 October 2025
- journal article
- Published by PAGEPress Publications in Italian Journal of Medicine
- Vol. 19 (4)
Abstract
Apical hypertrophic cardiomyopathy, also known as Yamaguchi syndrome, is a rare variant of hypertrophic cardiomyopathy characterized by thickening of the apical segment of the left ventricle. Due to its non-specific symptoms and the limitations of standard echocardiography, it often remains undiagnosed. This article summarizes current literature regarding the epidemiology, pathophysiology, diagnosis, management, and prognosis of Yamaguchi syndrome. A narrative literature review was conducted using PubMed, Scopus, Web of Science, UpToDate, and European Society of Cardiology guidelines, analyzing studies published between 2016 and 2024, with emphasis on clinical presentation, imaging techniques, and risk assessment for sudden cardiac death. The syndrome is more common in Asian populations and is rarely reported in Europe and the Balkans. Electrocardiography typically reveals deep negative T waves in precordial leads, while cardiac magnetic resonance imaging remains the most accurate diagnostic method. Although the overall prognosis is generally favorable, some patients remain at risk for sudden cardiac death, particularly those with documented fibrotic involvement identified by late gadolinium enhancement. Management is usually conservative, with periodic follow-up and individualized decisions regarding the implantation of an implantable cardioverter defibrillator. Raising awareness of this rare variant, particularly in the Balkan region, is essential for timely diagnosis and optimal management.Keywords
This publication has 32 references indexed in Scilit:
- Systematic Review and Meta-Analysis Comparing Long-Term Outcomes in Apical Versus Nonapical Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2025
- Clinical Characteristics and Long-Term Outcomes in Patients with Apical Hypertrophic CardiomyopathyESC Heart Failure, 2025
- Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk ScoreJACC: Advances, 2024
- Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and managementClinical Research in Cardiology, 2023
- Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed TomographyJournal of the American Society of Echocardiography, 2022
- Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and managementHeart Failure Reviews, 2018
- Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophyInternational Journal of Cardiology, 2015
- Erratum for Klarich KW, et al. “Risk of Death In Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy.” Am J Cardiol 2013;111:1784–1791The American Journal of Cardiology, 2013
- Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United StatesThe American Journal of Cardiology, 2003
- Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patientsThe American Journal of Cardiology, 1979